Search research articles
Contact Us
Filters
Showing results (81-90 of 85) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 85 results.
The Lancet. Oncology
|
July 10, 2020
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial
Andrea B Apolo, Rosa Nadal, Yusuke Tomita, et al.
JAMA Oncology
|
July 17, 2015
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma
Neha Korde, Mark Roschewski, Adriana Zingone, et al.
Nature Medicine
|
April 16, 2026
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial
Patrick J Grohar, Rachel Heise, Mary Frances Wedekind, et al.
The New England Journal of Medicine
|
June 20, 2024
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
Christopher Melani, Rahul Lakhotia, Stefania Pittaluga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations
David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 85) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 85 results.
The Lancet. Oncology
|
July 10, 2020
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial
Andrea B Apolo, Rosa Nadal, Yusuke Tomita, et al.
JAMA Oncology
|
July 17, 2015
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma
Neha Korde, Mark Roschewski, Adriana Zingone, et al.
Nature Medicine
|
April 16, 2026
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial
Patrick J Grohar, Rachel Heise, Mary Frances Wedekind, et al.
The New England Journal of Medicine
|
June 20, 2024
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
Christopher Melani, Rahul Lakhotia, Stefania Pittaluga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations
David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching, et al.
Page
of 9